ERBB2 and neoplasm: TNBCs lose estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), showing a robust immunosuppressive tumor microenvironment (TME) and high invasiveness and mortality 11, 12.